C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2009
11/25/2009	CN100562518C Novel arylethene-sulfonamides compounds
11/25/2009	CN100562316C Cis-imidazolines as MDM2 inhibitors
11/24/2009	US7622595 chemical intermediates to insecticides and anticoagulant inhibitors of factor Xa having a 1-halophenyl-3-trifluoromethylpyrazole moeity; 1-(1-chloro-2-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid
11/24/2009	US7622487 Piperidine derivative, process for producing the same, and use
11/24/2009	US7622473 'N-(2-chloro-6-methylphenyl)-2-[[(6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamides metabolites
11/24/2009	US7622471 Pyrazole derivatives having a pyridazine and pyridine functionality
11/24/2009	US7622461 Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
11/24/2009	US7622056 Pyridyl derivatives with substituents of electrons push-pull effect; compounds are colorless and have high thermal and photo stability as well as high compatibility in liquid crystal host; can reduce threshold voltage of cholesteric reflective displays, saving power and extending lifetime of driver ICs
11/24/2009	CA2485926C (imidazol-1-yl-methyl)-pyridazine as nmda receptor blocker
11/24/2009	CA2434381C Naphthostyrils
11/24/2009	CA2433197C Gyrase inhibitors and uses thereof
11/24/2009	CA2198745C Thermosetting resin compositions containing maleimide and/or vinyl compounds
11/19/2009	WO2009140624A2 Glucokinase activators
11/19/2009	WO2009140448A1 Tetrahydrocyclopenta[b]indole androgen receptor modulators
11/19/2009	WO2009139870A1 Oxo-imidazolyl compounds having antibacterial activity
11/19/2009	WO2009139373A1 Amide compound
11/19/2009	WO2009139340A1 Pyrazole compound
11/19/2009	WO2009138378A1 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of arway diseases
11/19/2009	WO2009094442A3 5-fluoro pyrimidine derivatives as fungicides
11/19/2009	WO2009074300A8 Hedgehog pathway antagonists and therapeutic applications thereof
11/19/2009	US20090286990 Process for preparing irbesartan
11/19/2009	US20090286974 Derivative having ppar agonistic activity
11/19/2009	US20090286973 Ligand-conjugated monomers
11/19/2009	US20090286841 Certain chemical entities, compositions, and methods
11/19/2009	US20090286801 Carbonylated (aza) cyclohexanes as dopamine d3 receptor ligands
11/19/2009	US20090286796 Compounds exhibiting type X sPLA2 inhibiting effect
11/19/2009	US20090286792 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
11/19/2009	US20090286791 Amide Compounds
11/19/2009	US20090286771 2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders
11/19/2009	US20090286758 Substituted n-phenyl-5-phenyl-pyrazolin-3-yl amides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity
11/19/2009	US20090286755 Potentiator of radiation therapy
11/19/2009	US20090286261 Method for assaying compounds or agents for ability to displace potent ligands of hematopoietic prostaglandin d synthase
11/19/2009	US20090286051 Anthrapyridone compound or salt thereof, magenta ink composition containing the same, and colored product
11/19/2009	US20090285988 Anthrapyridone compound, magenta ink composition and colored matter
11/19/2009	US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/19/2009	US20090285782 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
11/19/2009	CA2724629A1 Tetrahydrocyclopenta[b]indole androgen receptor modulators
11/19/2009	CA2724232A1 Sulfone compounds which modulate the cb2 receptor
11/19/2009	CA2724116A1 Glucokinase activators
11/19/2009	CA2724077A1 Amide compound
11/19/2009	CA2723938A1 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases
11/18/2009	EP2119706A1 Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of hgfr gene
11/18/2009	EP2119703A1 Novel indole derivative having inhibitory activity on i b kinase
11/18/2009	EP2118091A1 Pyrimidine substituted macrocyclic hcv inhibitors
11/18/2009	EP2118074A1 Compounds for the prevention and treatment of cardiovascular diseases
11/18/2009	EP2118069A2 Bis-aryl amide derivatives useful for the treatment of cancer
11/18/2009	EP2118067A1 Nicotinic acetylcholine receptor modulators
11/18/2009	EP2117540A1 New use of glutaminyl cyclase inhibitors
11/18/2009	EP2117526A2 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
11/18/2009	EP2117311A1 Therapeutic agents
11/18/2009	EP1928842B1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
11/18/2009	EP1910340B1 Indazolecarboxamide derivatives as 5ht4 receptor agonists
11/18/2009	EP1597229B1 Pyrrolidine derivatives as oxytocin antagonists
11/18/2009	EP1442026B9 Triazole derivatives as cyclooxygenase (cox) inhibitors
11/18/2009	EP1306372B1 Heterocycle derivatives and drugs
11/18/2009	EP1280781B1 5-ht 7 receptor antagonists
11/18/2009	EP1218354B1 Quinazoline derivatives and their use as pharmaceuticals
11/18/2009	EP0892789B2 Irreversible inhibitors of tyrosine kinases
11/18/2009	CN101583365A Triazine derivatives and their therapeutical applications
11/18/2009	CN101580521A Dendritic organic metal composition and electroluminescent device using same
11/18/2009	CN101580493A Poly-substituted miazines compound, preparation method and application thereof
11/18/2009	CN101580489A Nitrogenous heterocyclic ring compound and preparation method and application thereof
11/18/2009	CN100560585C New benzimidazole derivative
11/18/2009	CN100560584C Benzoazolypiperazine derivatives having MGLUR1- and MGLUR5-antagonistic activity
11/18/2009	CN100560566C Benzyloxy derivatives as MAOB inhibitors
11/17/2009	US7619094 Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus
11/17/2009	US7618981 Imidazopyridinyl-benzamide anti-cancer agents
11/17/2009	US7618978 Amides as BACE inhibitors
11/17/2009	US7618975 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis; antiproliferative, anticarcinogenic, antimetabolic agents; tubulin and topoisomerase II inhibitors; fungicides; synergistic administration with other anticarcinogenic agents
11/17/2009	US7618974 Gyrase inhibitors and uses thereof
11/17/2009	US7618971 Mitotic kinesin inhibitors
11/17/2009	US7618970 To treat inflammatory diseases, immune diseases and cancer; N-[(1R,3S)-3-Isopropyl-3-({4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}carbonyl)cyclopentyl]-3-methoxytetrahydro-2H-pyran-4-amine; side effect reduction; improved long term safety profile; oral administration; half life
11/17/2009	US7618968 Aryl triazines as LPAAT-β inhibitors and uses thereof
11/17/2009	US7618962 Pyrazolyl substituted xanthines
11/17/2009	CA2470519C Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5
11/17/2009	CA2463272C Piperazine derivatives with ccr1 receptor antagonist activity
11/17/2009	CA2450801C Drugs that enhance synaptic responses mediated by ampa receptors
11/17/2009	CA2444501C Phenylindoles for the treatment of hiv
11/17/2009	CA2417082C New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
11/17/2009	CA2382296C Selective cox-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines
11/17/2009	CA2206794C Novel 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives, their preparation and use as drugs
11/12/2009	WO2009137742A1 Process for the preparation of cyano-substituted-nitrogen-containing heteroaryl compounds
11/12/2009	WO2009137538A2 Fungicidal substituted azoles
11/12/2009	WO2009137270A2 Azetidine derivatives
11/12/2009	WO2009136995A2 Inhibitors of syk protein kinase
11/12/2009	WO2009136290A1 Functionalized pyrrolidines and use thereof as iap inhibitors
11/12/2009	WO2009136191A1 Chemical compounds
11/12/2009	WO2009136175A1 Compounds for use in stabilizing p53 mutants
11/12/2009	WO2009135842A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists
11/12/2009	WO2009115874A3 Novel heterocyclic compounds, pharmaceutical compositions containing them and processes for their preparation
11/12/2009	WO2009104021A3 Novel polymorphs and processes for their preparation
11/12/2009	WO2009080745A3 Perhydroquinoxaline derivatives as analgesics
11/12/2009	WO2009070241A3 Angiotensin ii receptor antagonists
11/12/2009	WO2009067686A3 Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof
11/12/2009	WO2007084435A8 Methods for treating hepatitis c
11/12/2009	US20090281328 Pdk-1/akt signaling inhibitors
11/12/2009	US20090281310 Cinnamide compound
11/12/2009	US20090281308 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/12/2009	US20090281307 Benzoimidazole compounds
11/12/2009	US20090281158 Prodrugs of cc-1065 analogs

1 ... 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 ... 626